docusate sodium, sennosides

FDA Drug Profile — Sankaijo

docusate sodium, sennosides is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Sankaijo. Available dosage form: tablet.

Drug details

Generic Name
docusate sodium, sennosides
Brand Names
Sankaijo
Application Number
M007
Sponsor
Sato Pharmaceutical Co., Ltd.
NDC Codes
1
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
DOCUSATE SODIUM, SENNOSIDES

Indications and Usage

Uses • relieves occasional constipation (irregularity) • generally produces a bowel movement in 6-12 hours

Warnings

Warnings Do not use • if you are now taking mineral oil, unless directed by a doctor • laxative products for longer than 1 week unless directed by a doctor Ask a doctor before use if you have • stomach pain • nausea • vomiting • noticed a sudden change in bowel habits that continues over a period of 2 weeks Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition. If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children. Overdose warning In case of overdose, get medical help or contact a Poison Control Center right away.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.